|
1
|
Esser N, Legrand-Poels S, Piette J, Scheen
AJ and Paquot N: Inflammation as a link between obesity, metabolic
syndrome and type 2 diabetes. Diabetes Res Clin Pract. 105:141–150.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shoelson SE, Herrero L and Naaz A:
Obesity, inflammation, and insulin resistance. Gastroenterology.
132:2169–2180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sing CF, Stengård JH and Kardia SL: Genes,
environment, and cardiovascular disease. Arterioscler Thromb Vasc
Biol. 23:1190–1196. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Loscalzo J and Welch G: Nitric oxide and
its role in the cardiovascular system. Prog Cardiovasc Dis.
38:87–104. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kraus WE: Genetic approaches for the
investigation of genes associated with coronary heart disease. Am
Heart J. 140:S27–S35. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hingorani AD, Liang CF, Fatibene J, Lyon
A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG,
O'Shaughnessy KM and Brown MJ: A common variant of the endothelial
nitric oxide synthase (Glu298-> Asp) is a major risk factor for
coronary artery disease in the UK. Circulation. 100:1515–1520.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Galavi HR, Saravani R, Alamdari AR,
Ranjbar N, Damani E and Khodakhier TN: Evaluating the effect of the
rs2229238 and the rs4845625 interleukin 6 receptor gene
polymorphisms on body mass index and the risk of type 2 diabetes in
an iranian study population. Int J High Risk Behav Addiction.
5:e332892016.
|
|
8
|
Saravani R, Irani Z and Galavi HR:
Evaluation of transcription factor 7 like 2 polymorphisms and
haplotypes in risk of type 2 diabetes. Revista Romana de Medicina
de Laborator. 24:423–430. 2016. View Article : Google Scholar
|
|
9
|
Saravani S, Miri H, Saravani R, Yari D,
Nakhaee A and Mahjoubifard M: Association of catalase (rs7943316)
and glutathione peroxidase-1 (rs1050450) polymorphisms with the
risk of type 2 diabetes (T2DM). Mol Genet Microbiol Virol.
30:216–220. 2015. View Article : Google Scholar
|
|
10
|
Lowenstein CJ, Dinerman JL and Snyder SH:
Nitric oxide: A physiologic messenger. Ann Intern Med. 120:227–237.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Karvonen J, Kauma H, Kervinen K, Rantala
M, Ikäheimo M, Päivänsalo M, Savolainen MJ and Kesäniemi YA:
Endothelial nitric oxide synthase gene Glu298Asp polymorphism and
blood pressure, left ventricular mass and carotid artery
atherosclerosis in a population-based cohort. J Intern Med.
251:102–110. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bressler J, Pankow JS, Coresh J and
Boerwinkle E: Interaction between the NOS3 gene and obesity as a
determinant of risk of type 2 diabetes: The atherosclerosis risk in
communities study. PLoS One. 8:e794662013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bang H, Edwards AM, Bomback AS, Ballantyne
CM, Brillon D, Callahan MA, Teutsch SM, Mushlin AI and Kern LM:
Development and validation of a patient self-assessment score for
diabetes risk. Ann Intern Med. 151:775–783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Steinberg HO, Chaker H, Leaming R, Johnson
A, Brechtel G and Baron AD: Obesity/insulin resistance is
associated with endothelial dysfunction. Implications for the
syndrome of insulin resistance. J Clin Invest. 97:2601–2610. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Marsden PA, Heng HH, Scherer SW, Stewart
RJ, Hall AV, Shi XM, Tsui LC and Schappert KT: Structure and
chromosomal localization of the human constitutive endothelial
nitric oxide synthase gene. J Biol Chem. 268:17478–17488.
1993.PubMed/NCBI
|
|
16
|
Ferguson JF, Phillips CM, McMonagle J,
Pérez-Martínez P, Shaw DI, Lovegrove JA, Helal O, Defoort C,
Gjelstad IM, Drevon CA, et al: NOS3 gene polymorphisms are
associated with risk markers of cardiovascular disease and interact
with omega-3 polyunsaturated fatty acids. Atherosclerosis.
211:539–544. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song Y, Manson JE, Tinker L, Rifai N, Cook
NR, Hu FB, Hotamisligil GS, Ridker PM, Rodriguez BL, Margolis KL,
et al: Circulating levels of endothelial adhesion molecules and
risk of diabetes in an ethnically diverse cohort of women.
Diabetes. 56:1898–1904. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Meigs JB, Hu FB, Rifai N and Manson JE:
Biomarkers of endothelial dysfunction and risk of type 2 diabetes
mellitus. JAMA. 291:1978–1986. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Möllsten A, Lajer M, Jorsal A and Tarnow
L: The endothelial nitric oxide synthase gene and risk of diabetic
nephropathy and development of cardiovascular disease in type 1
diabetes. Molecular genetics and metabolism. 97:80–84. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li J, Tao F, Wu X, Tan Y, He L and Lu H:
Polymorphic variations in manganese superoxide dismutase (MnSOD)
and endothelial nitric oxide synthase (eNOS) genes contribute to
the development of type 2 diabetes mellitus in the Chinese Han
population. Genet Mol Res. 14:12993–13002. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
American Diabetes Association, . Standards
of medical care in diabetes. Diabetes Care. 27 Suppl 1:S15–S35.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Saravani R, Galavi HR, Ranjbar N and
Alamdari AR: ATP-binding cassette transporter A1 polymorphisms and
haplotypes in risk of type 2 diabetes. Gene Cell Tissue.
4:e436772016. View Article : Google Scholar
|
|
23
|
Saravani S, Yari D, Saravani R and
Ahmadabadi CA: Association of COL4A3 (rs55703767), MMP-9 (rs17576)
and TIMP-1 (rs6609533) gene polymorphisms with susceptibility to
type 2 diabetes. Biomed Rep. 6:329–334. 2017.PubMed/NCBI
|
|
24
|
Mousavi M, Saravani R, Modrek MJ,
Shahrakipour M and Sekandarpour S: Detection of toxoplasma gondii
in diabetic patients using the nested PCR assay via RE and B1
genes. Jundishapur J Microbiol. 9:e294932016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Haffner SM, Lehto S, Rönnemaa T, Pyörälä K
and Laakso M: Mortality from coronary heart disease in subjects
with type 2 diabetes and in nondiabetic subjects with and without
prior myocardial infarction. N Engl J Med. 339:229–234. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Stern MP and Haffner SM: Body fat
distribution and hyperinsulinemia as risk factors for diabetes and
cardiovascular disease. Arteriosclerosis. 6:123–130. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hink U, Li H, Mollnau H, Oelze M, Matheis
E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, et al:
Mechanisms underlying endothelial dysfunction in diabetes mellitus.
Circ Res. 88:E14–E22. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Johnstone MT, Creager SJ, Scales KM, Cusco
JA, Lee BK and Creager MA: Impaired endothelium-dependent
vasodilation in patients with insulin-dependent diabetes mellitus.
Circulation. 88:2510–2516. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
De Vriese AS, Verbeuren TJ, van de Voorde
J, Lameire NH and Vanhoutte PM: Endothelial dysfunction in
diabetes. Br J Pharmacol. 130:963–974. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
McVeigh G, Brennan G, Johnston G,
McDermott BJ, McGrath LT, Henry WR, Andrews JW and Hayes JR:
Impaired endothelium-dependent and independent vasodilation in
patients with type 2 (non-insulin-dependent) diabetes mellitus.
Diabetologia. 35:771–776. 1992.PubMed/NCBI
|
|
31
|
Kahn BB and Flier JS: Obesity and insulin
resistance. J Clin Invest. 106:473–481. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Haffner SM: Pre-diabetes, insulin
resistance, inflammation and CVD risk. Diabetes Res Clin Pract. 61
Suppl 1:S9–S18. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Caballero AE, Arora S, Saouaf R, Lim SC,
Smakowski P, Park JY, King GL, LoGerfo FW, Horton ES and Veves A:
Microvascular and macrovascular reactivity is reduced in subjects
at risk for type 2 diabetes. Diabetes. 48:1856–1862. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Balkestein EJ, van Aggel-Leijssen DP, van
Baak MA, Struijker-Boudier HA and Van Bortel LM: The effect of
weight loss with or without exercise training on large artery
compliance in healthy obese men. J Hypertens. 17:1831–1835. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rittig K, Hieronimus A, Thamer C, Machann
J, Peter A, Stock J, Schick F, Fritsche A, Stefan N, Häring HU and
Balletshofer B: Reducing visceral adipose tissue mass is essential
for improving endothelial function in type 2 diabetes prone
individuals. Atherosclerosis. 212:575–579. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Thameem F, Puppala S, Arar NH, Stern MP,
Blangero J, Duggirala R and Abboud HE: Endothelial nitric oxide
synthase (eNOS) gene polymorphisms and their association with type
2 diabetes-related traits in Mexican Americans. Diab Vasc Dis Res.
5:109–113. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen F, Li YM, Yang LQ, Zhong CG and
Zhuang ZX: Association of NOS2 and NOS3 gene polymorphisms with
susceptibility to type 2 diabetes mellitus and diabetic nephropathy
in the Chinese Han population. IUBMB life. 68:516–525. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Conen D, Glynn RJ, Buring JE, Ridker PM
and Zee RY: Renin-angiotensin and endothelial nitric oxide synthase
gene polymorphisms are not associated with the risk of incident
type 2 diabetes mellitus: A prospective cohort study. J Intern Med.
263:376–385. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zintzaras E, Papathanasiou AA and
Stefanidis I: Endothelial nitric oxide synthase gene polymorphisms
and diabetic nephropathy: a HuGE review and meta-analysis. Genet
Med. 11:695–706. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Makuc J and Petrovic D: No association
between NOS2 and NOS3 polymorphisms and diabetic nephropathy in
type 2 diabetics. Central European Journal of Biology. 7:404–410.
2012.
|
|
41
|
Chen Y, Huang H, Zhou J, et al:
Polymorphism of the endothelial nitric oxide synthase gene is
associated with diabetic retinopathy in a cohort of West Africans.
Mol Vis. 13:2142–2147. 2007.PubMed/NCBI
|
|
42
|
Zheleznyakova A, Vikulova O, Nosikov V and
Shestakova M: The impact of polymorphisms in NOS3, APOB, KCNJ11,
TCF7L2 genes on development of chronic kidney disease in type 2
diabetic patients. Exper Clin Endoc Diabetes. 122:LB162014.
|
|
43
|
Zakerjafari M, Mayali AM and Tavangar P:
Evaluation of NOS3 gene rs1800779 polymorphism in Iranian patients
affected by coronary-heart disease patients and normal individuals.
Adv Biores. 7:16–21. 2016.
|
